Galectin Therapeutics
Price & Volume
Stats
See more52W Range | $2.03-$7.13 |
Market Cap | $285.1M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.41 |
News
See moreYahoo Finance • 9 days ago
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
Yahoo Finance • 9 days ago
Galectin Aligns With FDA Feedback To Advance Belapectin In MASH Cirrhosis And Portal Hypertension
Yahoo Finance • 10 days ago
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
Yahoo Finance • 6 months ago
Galectin Advances Belapectin Program With FDA Feedback And Secures $10 Million Credit Line
About
CEO | Mr. Joel Lewis CPA |
CFO | Mr. Jack W. Callicutt CPA |
Address | 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |